| Literature DB >> 23696873 |
Jacopo Lenzi1, Raffaele Lombardi, Davide Gori, Nicola Zanini, Dario Tedesco, Michele Masetti, Elio Jovine, Maria Pia Fantini.
Abstract
BACKGROUND: The relationship between hospital volumes and short-term patients' outcomes of colon cancer (CC) surgery is not well established in the literature. Moreover, evidence about short-term outcomes of urgent compared with elective CC procedures is scanty. The aims of this study are 1) to determine whether caseloads and other hospital characteristics are associated with short-term outcomes of CC surgery; 2) to compare the outcomes of urgent and elective CC surgery.Entities:
Mesh:
Year: 2013 PMID: 23696873 PMCID: PMC3656123 DOI: 10.1371/journal.pone.0064245
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient characteristics.
| Study sample |
|
|
| 70.16 [11.34] |
|
| |
| Male | 7,722 (54.38) |
| Female | 6,478 (45.62) |
|
| 11 |
|
| |
| No | 6,328 (44.56) |
| Yes | 7,872 (55.44) |
|
| |
| Diabetes | 1,370 (9.65) |
| Disorders of lipoid metabolism | 295 (2.08) |
| Hematologic diseases | 2,484 (17.49) |
| Hypertensive disease | 1,845 (12.99) |
| Old acute myocardial infarction | 312 (2.20) |
| Other forms of ischemic heart disease | 707 (4.98) |
| Heart failure | 289 (2.04) |
| Ill-defined descriptions and complications of heart disease | 84 (0.59) |
| Rheumatic heart disease | 129 (0.91) |
| Cardiomyopathies | 88 (0.62) |
| Acute endocarditis and myocarditis | 7 (0.05) |
| Other cardiac diseases | 211 (1.49) |
| Conduction disorders and cardiac dysrhythmias | 613 (4.32) |
| Cerebrovascular diseases | 593 (4.18) |
| Vascular diseases | 403 (2.84) |
| Chronic obstructive pulmonary disease (COPD) | 1,149 (8.09) |
| Chronic nephropathies | 296 (2.08) |
| Chronic diseases (liver, pancreas and intestine) | 360 (2.54) |
| History of tumors | 6,126 (43.14) |
| Tumors other than colorectal cancer at theindex admission | 113 (0.80) |
|
| |
| No | 11,899 (83.80) |
| Yes | 2,301 (16.20) |
|
| |
| Partial colectomy | 13,424 (94.59) |
| Total colectomy | 268 (1.89) |
| Other | 499 (3.52) |
|
| |
| Elective | 10,831 (76.27) |
| Urgent | 3,369 (23.73) |
Patients with unknown type of procedure were not included (n = 9).
SD, standard deviation; IQR, interquartile range.
GSU and hospital characteristics.
| GSU volume | Non-teaching public hospitals ( | Teaching public hospitals ( | Private hospitals ( | ||||
| Non-focused GSUs (%) | Focused GSUs | Non-focused GSUs (%) | Focused GSUs | Non-focused GSUs (%) | Focused GSUs | ||
| Low-volume (<40) | 26 (74.3) | 2 (16.6) | 5 (71.4) | 3 (37.5) | 22 (100.0) | 2 (100.0) | |
| Intermediate-volume (40–64) | 8 (22.9) | 5 (41.7) | 0 (0.0) | 4 (50.0) | 0 (0.0) | 0 (0.0) | |
| High-volume (≥65) | 1 (2.9) | 5 (41.7) | 2 (28.6) | 1 (12.5) | 0 (0.0) | 0 (0.0) | |
| Total | 35 (100.0) | 12 (100.0) | 7 (100.0) | 8 (100.0) | 22 (100.0) | 2 (100.0) | |
Defined as GSUs with over 5% CC cases over total operations.
GSU, General surgery unit.
Crude relationships of patient characteristics with outcomes.
| Characteristics | 30-day mortality | Re-intervention | 30-day re-admission | ||||||
| No( | Yes( |
| No( | Yes( |
| No( | Yes( |
| |
|
| 69.93 [11.27] | 81.72 [8.55] | <0.001 | 70.10 [11.29] | 71.80 [12.51] | 0.001 | 71.23 [11.05] | 67.42 [11.60] | <0.001 |
|
| 0.540 | 0.540 | 0.021 | ||||||
| Male | 7,578 (54.42) | 144 (52.55) | 7,461 (54.33) | 261 (55.77) | 5,490 (53.78) | 2,232 (55.93) | |||
| Female | 6,348 (45.58) | 130 (47.45) | 6,271 (45.67) | 207 (44.23) | 4,719 (46.22) | 1,759 (44.07) | |||
|
| <0.001 | 0.016 | 0.102 | ||||||
| No | 6,250 (44.88) | 78 (28.47) | 6,145 (44.75) | 183 (39.10) | 4,506 (44.14) | 1,822 (45.65) | |||
| Yes | 7,676 (55.12) | 196 (71.53) | 7,587 (55.25) | 285 (60.90) | 5,703 (55.86) | 2,169 (54.35) | |||
|
| |||||||||
| Diabetes | 1,343 (9.64) | 27 (9.85) | 0.907 | 1,320 (9.61) | 50 (10.68) | 0.440 | 1,024 (10.03) | 346 (8.67) | 0.014 |
| Disorders of lipoid metabolism | 285 (2.05) | 10 (3.65) | 0.065 | 289 (2.10) | 6 (1.28) | 0.220 | 209 (2.05) | 86 (2.15) | 0.686 |
| Hematologic diseases | 2,411 (17.31) | 73 (26.64) | <0.001 | 2,343 (17.06) | 141 (30.13) | <0.001 | 1,794 (17.57) | 690 (17.29) | 0.689 |
| Hypertensive disease | 1,782 (12.80) | 63 (22.99) | <0.001 | 1,783 (12.98) | 62 (13.25) | 0.868 | 1,376 (13.48) | 469 (11.75) | 0.006 |
| Old acute myocardial infarction | 304 (2.18) | 8 (2.92) | 0.410 | 306 (2.23) | 6 (1.28) | 0.170 | 244 (2.39) | 68 (1.70) | 0.012 |
| Other forms of ischemic heartdisease | 672 (4.83) | 35 (12.77) | <0.001 | 682 (4.97) | 25 (5.34) | 0.714 | 533 (5.22) | 174 (4.36) | 0.034 |
| Heart failure | 267 (1.92) | 22 (8.03) | <0.001 | 280 (2.04) | 9 (1.92) | 0.861 | 228 (2.23) | 61 (1.53) | 0.007 |
| Ill-defined descriptionsand complications ofheart disease | 78 (0.56) | 6 (2.19) | 0.006 | 82 (0.60) | 2 (0.43) | 1.000 | 66 (0.65) | 18 (0.45) | 0.172 |
| Rheumatic heart disease | 123 (0.88) | 6 (2.19) | 0.039 | 123 (0.90) | 6 (1.28) | 0.323 | 99 (0.97) | 30 (0.75) | 0.218 |
| Cardiomyopathies | 82 (0.59) | 6 (2.19) | 0.007 | 84 (0.61) | 4 (0.85) | 0.539 | 69 (0.68) | 19 (0.48) | 0.173 |
| Acute endocarditis and myocarditis | 7 (0.05) | 0 (0.00) | 1.000 | 6 (0.04) | 1 (0.21) | 0.209 | 6 (0.06) | 1 (0.03) | 0.681 |
| Other cardiac diseases | 204 (1.46) | 7 (2.55) | 0.131 | 195 (1.42) | 16 (3.42) | <0.001 | 165 (1.62) | 46 (1.15) | 0.040 |
| Conduction disorders and cardiac dysrhythmias | 581 (4.17) | 32 (11.68) | <0.001 | 584 (4.25) | 29 (6.20) | 0.042 | 454 (4.45) | 159 (3.98) | 0.222 |
| Cerebrovascular diseases | 557 (4.00) | 36 (13.14) | <0.001 | 574 (4.18) | 19 (4.06) | 0.898 | 444 (4.35) | 149 (3.73) | 0.099 |
| Vascular diseases | 378 (2.71) | 25 (9.12) | <0.001 | 389 (2.83) | 14 (2.99) | 0.839 | 322 (3.15) | 81 (2.03) | <0.001 |
| COPD | 1,100 (7.90) | 49 (17.88) | <0.001 | 1,107 (8.06) | 42 (8.97) | 0.476 | 866 (8.48) | 283 (7.09) | 0.006 |
| Chronic nephropathies | 277 (1.99) | 19 (6.93) | <0.001 | 288 (2.10) | 8 (1.71) | 0.564 | 228 (2.23) | 68 (1.70) | 0.047 |
| Chronic diseases (liver,pancreas and intestine) | 348 (2.50) | 12 (4.38) | 0.050 | 351 (2.56) | 9 (1.92) | 0.392 | 263 (2.58) | 97 (2.43) | 0.620 |
| History of tumors | 5,961 (42.80) | 165 (60.22) | <0.001 | 5,929 (43.18) | 197 (42.09) | 0.642 | 4,417 (43.27) | 1,709 (42.82) | 0.631 |
| Tumors other thancolorectal cancer atthe index admission | 110 (0.79) | 3 (1.09) | 0.482 | 108 (0.79) | 5 (1.07) | 0.425 | 74 (0.72) | 39 (0.98) | 0.128 |
|
| <0.001 | 0.154 | <0.001 | ||||||
| No | 11,712 (84.10) | 187 (68.25) | 11,518 (83.88) | 381 (81.41) | 8,919 (87.36) | 2,980 (74.67) | |||
| Yes | 2,214 (15.90) | 87 (31.75) | 2,214 (16.12) | 87 (18.59) | 1,290 (12.64) | 1,011 (25.33) | |||
|
| <0.001 | 0.001 | 0.001 | ||||||
| Partial colectomy | 13,196 (94.81) | 228 (83.52) | 12,993 (94.68) | 431 (92.10) | 9,693 (94.98) | 3,731 (93.60) | |||
| Total colectomy | 261 (1.88) | 7 (2.56) | 262 (1.91) | 6 (1.28) | 188 (1.84) | 80 (2.01) | |||
| Other | 461 (3.31) | 38 (13.92) | 468 (3.41) | 31 (6.62) | 324 (3.18) | 175 (4.39) | |||
|
| <0.001 | <0.001 | <0.001 | ||||||
| Elective | 10,731 (77.06) | 100 (36.50) | 10,602 (77.21) | 229 (48.93) | 8,004 (78.40) | 2,827 (70.83) | |||
| Urgent | 3,195 (22.94) | 174 (63.50) | 3,130 (22.79) | 239 (51.07) | 2,205 (21.60) | 1,164 (29.17) | |||
Patients with unknown type of procedure were not included (n = 9).
Multilevel logistic regression analysis: adjusted relationships of GSU characteristics with outcomes.
| GSU characteristics | 30-day mortality (elective pts) | 30-day mortality (urgent pts) | Re-intervention | 30-day re-admission | ||||||||
| aOR |
| 95% CI | aOR |
| 95% CI | aOR |
| 95% CI | aRR |
| 95% CI | |
|
| ||||||||||||
| Low-volume (<40) | 1 | 1 | ||||||||||
| Intermediate-volume (40–64) | 0.566 | 0.073 | (0.304–1.055) | 1.025 | 0.916 | (0.645–1.630) | – | – | ||||
| High-volume (≥65) | 0.352 | 0.004 | (0.174–0.713) | 0.723 | 0.239 | (0.421–1.241) | – | – | ||||
|
| ||||||||||||
| Non-focused (<5%) | 1 | 1 | ||||||||||
| Focused (≥5%) | – | – | 0.673 | 0.034 | (0.467–0.971) | 0.875 | 0.044 | (0.780–0.981) | ||||
| Pseudo | 0.429 | 0.367 | 0.305 | 0.129 | ||||||||
Adjusted for significant patient-level covariates, including sex, age, cardiomyopathies, heart failure, COPD, chronic diseases (liver, pancreas, intestine), vascular diseases, cerebrovascular diseases, history of tumors, admission status, type of procedure and presence of metastases.
Adjusted for significant patient-level covariates, including sex, age, hematologic diseases, other cardiac diseases, old acute myocardial infarction, admission status and type of procedure.
Adjusted for significant patient-level covariates, including sex, age, length of stay, diabetes, other cardiac diseases, hematologic diseases, other cardiac diseases, vascular diseases, cerebrovascular diseases, history of tumors, admission status and presence of metastases.
30-day re-admission was a common outcome and the OR is not a good approximation to the RR, so we estimated the RR of re-admission using Flanders and Rhodes method [21].
Pseudo R indicates how much of the total variation of the phenomenon (patient-, GSU- and hospital-level variance) was explained by the covariates included in the model.
pts, patients; OR, odds ratio; CI, confidence interval; RR, relative risk.
Multilevel logistic regression analysis: variations among GSUs in 30-day mortality, re-intervention and 30-day re-admission.
| 30-day mortality(elective pts) | 30-day mortality(urgent pts) | Re-intervention | 30-day re-admission | |
|
| 0.471 | 0.209 | 0.634 | 0.470 |
|
| 0.002 | 0.067 | <0.001 | <0.001 |
|
| 42.07 | 0.00 | 7.45 | 6.00 |
GSU- and hospital-level variance is a measure of GSU variations in mortality, re-intervention and re-admission. It is calculated as the sum of hospital-level variance and GSU-level variance, both computed using the restricted maximum likelihood method.
Determined via likelihood-ratio test of variance = 0.
PCV (proportional change in variance) is calculated as the percentage decrease between the variance of model M1 and the variance of model M2. It measures the percentage variance attributable to GSU characteristics.